Martin Makary, President Donald Trump's nominee to run the U.S. FDA, on Thursday promised to convene the agency's vaccine advisory committee, but did not commit to rescheduling a canceled meeting to discuss the composition of the next seasonal flu vaccine.

Senators asked Makary about the FDA’s decision to cancel a scheduled meeting of its outside committee of vaccine experts to discuss the design of this year’s influenza vaccine

Days after the U.S. FDA cancelled an annual meeting to discuss the makeup of the following season's flu vaccine, FDA Commissioner nominee Marty Makary pledged to review that decision if he is confirmed.